MARC Record from Library of Congress

LEADER: 01785cam a2200337 i 4500
001 2014013165
003 DLC
005 20150204081956.0
008 140402m20149999flua b 001 0 eng
010 $a 2014013165
020 $a9781466599475 (hardcover : alk. paper)
035 $a(DNLM)101629567
040 $aDNLM/DLC$cDLC$erda$dDLC
042 $apcc
050 00 $aRS199.5$b.N368 2014
060 10 $aQV 785
082 00 $a615.1/9$223
245 00 $aNanotechnology and drug delivery /$c[edited by] Jose L. Arias.
264 1 $aBoca Raton :$bTaylor & Francis,$c2014-
300 $avolumes :$billustrations ;$c24 cm
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
504 $aIncludes bibliographical references and index.
500 $aVolume 1. Nanoplatforms in Drug Delivery.
520 $a"Pharmacotherapy is often limited by the inefficient activity and severe toxicity of drug molecules. Nanotechnology offers a revolutionary and definitive approach for the efficient delivery of drug molecules to non-healthy tissues and cells. This first volume of a series of two volumes analyzes the basics in the development of drug-loaded nanoplatforms, the so-called nanomedicines. Special attention is given to physicochemical engineering, pharmacokinetics, biocompatibility and biodegradability, representative nanoplatforms (based on lipids, polymers, cyclodextrins, metals, carbon, silica, iron oxides, etc.), and advanced nano-engineering strategies for passive, ligand-mediated, and/or stimuli-sensitive drug delivery and release"--Provided by publisher.
650 12 $aDrug Delivery Systems.
650 12 $aNanoparticles.
650 22 $aDrug Design.
650 22 $aNanotechnology$xmethods.
700 1 $aArias, José L.,$eeditor.